Compare CYTK & COLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYTK | COLB |
|---|---|---|
| Founded | 1997 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 8.6B |
| IPO Year | 2004 | 1996 |
| Metric | CYTK | COLB |
|---|---|---|
| Price | $78.68 | $30.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 14 |
| Target Price | ★ $89.26 | $31.46 |
| AVG Volume (30 Days) | 1.7M | ★ 2.6M |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 5.08% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.66 |
| Revenue | $13,368,000.00 | ★ $177,000,000.00 |
| Revenue This Year | $7.37 | $31.52 |
| Revenue Next Year | $310.19 | $2.90 |
| P/E Ratio | ★ N/A | $45.24 |
| Revenue Growth | N/A | ★ 18.94 |
| 52 Week Low | $31.99 | $22.12 |
| 52 Week High | $80.20 | $32.70 |
| Indicator | CYTK | COLB |
|---|---|---|
| Relative Strength Index (RSI) | 62.37 | 54.50 |
| Support Level | $59.07 | $28.28 |
| Resistance Level | $79.66 | $31.11 |
| Average True Range (ATR) | 3.20 | 0.69 |
| MACD | 0.51 | 0.05 |
| Stochastic Oscillator | 83.65 | 54.56 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.